Open Net Zero logo
Derivation and Evaluation of Putative Adverse Outcome Pathways for Effects of Cycylooxygenase inhibitors on Reproductive Processes in Female Fish
OwnerUnited State Environmental Protection Agency - view all
Update frequencyunknown
Last updatedabout 1 year ago
Overview

Fathead minnows (Pimephales promelas) were exposed to 100 ug/L indomethacin, 200 ug/L ibuprofen, or 20 ug/L celecoxib for 96 h. Effects on cycloxygenase enzyme activity in ovary, prostaglandin F2alpha concentrations in plasma, 17beta-estradiol concentrations in plasma, and vitellogenin concentrations in plasma were measured. Gene expression in ovary samples was evaluated using a 15,000 probe oligonucleotide microarray. Transcriptomics data (raw data and normalized) are available through the National Center for Biotechnology Information, Gene Expression Omnibus (GEO), accession number GSE72976. Metabolite profiles in liver tissue were measured by proton nuclear magnetic resonance. In addition to these data, the data set also contains identification of differentially expressed genes, pathway enrichment and gene set enrichment analyes, ToxCast data for indomethacin and celecoxib, chemical-gene interaction data derived from the Comparative Toxicogenomics database, and results from Level 1, Level 2, and Level 3 SeqAPASS analyses that examine conservation of target proteins across species (https://seqapass.epa.gov/seqapass/). This dataset is associated with the following publication: Martinovic-Weigelt, D., A. Mehinto, G. Ankley , J. Berninger, T. Collette , J. Davis , N. Denslow, E. Durhan, E. Eid, D. Ekman , K. Jensen , M. Kahl , C. LaLone , Q. Teng , and D. Villeneuve. Derivation and evaluation of putative adverse outcome pathways for the effects of cyclooxygenase inhibitors on reproductive processes in female fish. TOXICOLOGICAL SCIENCES. Society of Toxicology, 156(2): 344-361, (2017).

adverse outcome pathwayaquatic ecosystemsecotoxicologyendocrine disruptionscreening and prioritization
Additional Information
KeyValue
dcat_modified2018-10-25
dcat_publisher_nameU.S. EPA Office of Research and Development (ORD)
guidhttps://doi.org/10.23719/1503124
ib1_trust_framework[]
language
Files
  • API
    6de0eee0-5133-4f9d-98c5-648ee873fc5f
  • XLSX
    89fd56fe-c8b0-4545-9f5f-4db807bb6c17
  • XLSX
    aaa7baa0-4fe2-4d03-aa14-27cb6e019b0c
  • XLSX
    7755a3e4-0498-4007-8635-4f906ce015a5
  • XLSX
    a8143ae3-24cd-46f5-b436-cbc0ef96d619
  • CSV
    02d5a247-daa5-420f-b4d4-97ad143fb826
  • CSV
    b216fad5-e34d-4c4c-bf7a-0c745d9a1e58
  • CSV
    c9953a1a-edbe-40cb-ba15-aabb575388d0
  • CSV
    dd1db421-6664-4d1a-882c-a5f97e8dcb82
  • XLSX
    212a8c3e-50bb-485f-b3a4-3d90f7e0ace2
  • XLSX
    edead17e-6b81-45f5-bb65-a82fd9e348e9
  • XLSX
    1fd23d11-d475-4107-ad2e-89602aea9a8e
  • XLSX
    3aadadd3-2531-4f25-b51b-af65a4562df5
  • XLSX
    0e6f1cea-f12a-4fc5-a4f3-6f73fce762f4
  • XLSX
    66c1d13e-2978-46e4-a017-89c0345d973e
Share this Dataset
derivation-and-evaluation-of-putative-adverse-outcome-pathways-for-effects-of-cycylooxygenase-i
Access and Licensing
Access conditionsAccess control: Unknown
License conditionsLicense: